Welcome to the e-CCO Library!

P352: Melanoma in a population-based Australian inflammatory bowel disease cohort
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

G. Hume*

Created: Friday, 22 February 2019, 9:49 AM
P352: Occurrence of moderate to severe anaemia and utilization and efficacy of intravenous iron therapies in a nationwide cohort of Inflammatory Bowel Disease patients
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Khan, N.(1,2)*;Patel, M.(1);Sundararajan, R.(1);
Created: Friday, 14 July 2023, 11:05 AM
P352: TDM of infliximab in IBD-patients: which pharmacokinetic marker to use?
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Berends*1,2, R. Mathôt1, A. Strik2, A. De Vries3, M. Löwenberg2, G. D'Haens2

Created: Friday, 22 February 2019, 9:41 AM
P352: Ustekinumab is associated with superior treatment persistence compared to vedolizumab in Crohn’s disease patients who failed to anti-TNF therapy: results from a Hungarian cohort study
Year: 2022
Source: ECCO'22
Authors: Bacsur, P.(1);Resál, T.(1);Miheller, P.(2);Szamosi, T.(3);Schäfer, E.(3);Sarlós, P.(4);Iliás, Á.(5);Szántó, K.J.(1);Rutka, M.(1);Bálint, A.(1);Fábián, A.(1);Bor, R.(1);Zoltán, S.(1);Matuz, M.(6);Molnár, T.(1);Farkas, K.(1);
Created: Friday, 11 February 2022, 3:52 PM
P353 Assessing compliance to screening for infectious diseases and vaccination in patients newly diagnosed with inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

R. Pringle, A. Assadsangabi

Created: Thursday, 30 January 2020, 10:12 AM
P353: Aberrant brain structural large-scale connectome in Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Thomann*1, M. Griebe2, M. Ebert1, P. Thomann3, W. Reindl1

Created: Friday, 22 February 2019, 9:41 AM
P353: Agreement between patients, senior and junior physicians on disease activity and burden scoring in inflammatory bowel disease, using a tele-monitoring platform
Year: 2022
Source: ECCO'22
Authors: Mangia, M.(1,2);Giuffrida, E.(1,3);Figini, V.(4);Colombo, A.(1);Carli, E.(1);Mendolaro, M.(1);Lavagna, A.(1);Lia, C.(5);Bonina, M.(5);Martínez De Carnero, F.(5);Morello, E.(1);Cosimato, M.(1);Rocca, R.(1);Pagana, G.(4,5);Daperno, M.(1);
Created: Friday, 11 February 2022, 3:52 PM
P353: Clinical characteristics of ulcerative colitis associated with primary sclerosing cholangitis in Korea: An update
Year: 2018
Source: ECCO '18 Vienna
Authors:

S.-H. Lee1*, K. Chang1, M.-J. Kim2, E.M. Song1, S.W. Hwang1,3, D.-H. Yang1, J.-S. Byeon1, S.-J. Myung1, S.-K. Yang1,3, B.D. Ye1,3

Created: Thursday, 21 February 2019, 9:14 AM
P353: Endoscopy-based management within the first year after surgery decreases the risk of clinical and surgical postoperative recurrences in Crohn’s disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A.-L. Boucher1, B. Pereira2, S. Decousus3, M. Goutte1, 4, F. Goutorbe1, A. Dubois5, J. Gagnière5, C. Borderon6, J. Joubert3, D. Pezet5, M. Dapoigny1, P. Dechelotte3, G. Bommelaer1, 4, A. Buisson*1, 4

Created: Friday, 22 February 2019, 9:49 AM
P353: Long-term safety of adalimumab in patients with Crohn's disease: final data from PYRAMID registry
Year: 2017
Source: ECCO '17 Barcelona
Authors:

D'Haens G.*1, Reinisch W.2, Satsangi J.3, Loftus Jr. E.V.4, Panaccione R.5, Alperovich G.6, Kalabic J.7, Bereswill M.7, Arikan D.8, Petersson J.8, Robinson A.M.8

Created: Wednesday, 20 February 2019, 10:36 AM
P353: Pan-enteric capsule endoscopy enables assessment of mucosal healing after biologic treatment initiation in Crohn’s disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Volkers, A.(1);Bosuyt, P.(2);de Jong, J.(1);D'Haens, G.(1);Löwenberg, M.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P353: Ulcerative Colitis in the IBSEN III study: Frequent use of biologics and low colectomy rates first year of disease.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Strande, V.(1,2,3)*;Lund, C.(3,4);Småstuen, M.C.(4,5);Bengtson, M.B.(6);Cetinkaya, R.B.(7);Detlie, T.E.(3,8);Frigstad, S.O.(9);Medhus, A.W.(3,4);Henriksen, M.(10);Holten, K.I.A.(3,10);Hovde, Ø.(3,11);Huppertz-Hauss, G.(12);Johansen, I.(13,14);Olsen, B.C.(3,12);Pallenschat, J.(15);Perminow, G.(16);Ricanek, P.(2,8);Torp, R.(17);Tønnessen, T.(18);Vatn, S.(8);Aabrekk, T.B.(3,6);Opheim, R.(4,14);Høivik, M.L.(3,4);Kristensen, V.A.(1,4);
Created: Friday, 14 July 2023, 11:05 AM
P354 Objectively measured time spent sitting, standing upright, and stepping is associated with disease severity and faecal calprotectin in patients with ulcerative colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Raman1, J. Vallance2, K. Lyden3, S. Alana4, C. Ohland5, K. McCoy5, S. Kaur1, R. Panaccione1, R. Reimer6, L. Taylor1

Created: Thursday, 30 January 2020, 10:12 AM
P354: A prospective randomised study: 2 mg/kg/d of azathioprine is an appropriate dosage for Chinese patients with Crohn’s disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

Y. Zhang*, J. Xia, Q. Cao

Created: Friday, 22 February 2019, 9:49 AM
P354: Application of the clinical decision support tool to predict treatment outcomes in Crohn's Disease patients treated with vedolizumab subcutaneous formulation
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Dulai, P.(1)*;Lindner, D.(2);Agboton, C.(3);Alric, H.(4);Bamias, G.(5);Peyrin-Biroulet, L.(6);
Created: Friday, 14 July 2023, 11:05 AM
P354: Early treatment versus active surveillance after ileocolic resection in Crohn’s disease: a retrospective cohort study.
Year: 2021
Source: ECCO'21 Virtual
Authors: Haenen, S.(1);Sabino, J.(1);Bislenghi, G.(2);D'Hoore, A.(2);Ferrante, M.(1);Vermeire, S.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P354: Immunological response to vaccination against SARS-COV-2 infection in Inflammatory Bowel Disease patients under immunosuppressive therapy: should we prioritize an additional booster injection?
Year: 2022
Source: ECCO'22
Authors: Macedo Silva, V.(1,2,3);Lima Capela, T.(1,2,3);Freitas, M.(1,2,3);Cúrdia Gonçalves, T.(1,2,3);Boal Carvalho, P.(1,2,3);Dias de Castro, F.(1,2,3);Moreira, M.J.(1,2,3);Cotter, J.(1,2,3);
Created: Friday, 11 February 2022, 3:52 PM
P354: Perceived Quality of Care is associated to quality of life, work productivity and gender but not disease phenotype: a prospective study in a high-volume IBD centre
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

L. Gonczi*1, Z. Kurti1, C. Verdon2, J. Reinglas2, R. Kohen2, I. Morin2, K. Chavez2, T. Bessissow2, W. Afif2, G. Wild2, E. Seidman2, A. Bitton2, P. Lakatos2

Created: Friday, 22 February 2019, 9:41 AM
P354: Refinement and confirmation of psychometric properties of the Inflammatory Bowel Disease Distress Scale (IBD-DS): A new tool to measure disease-specific distress
Year: 2018
Source: ECCO '18 Vienna
Authors:

L. Dibley1,2*, W. Czuber-Dochan3, S. Woodward3, T. Wade3, P. Bassett4, J. Sturt3, C. Norton3, The IBD-DS Patient and Public Involvement Team3

Created: Thursday, 21 February 2019, 9:14 AM
P354: The effect of value based health care delivery for inflammatory bowel diseases on outcomes of patients
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Zand A., Aredas E., Duran N., DiNicola C., Lacey P., Arenas A., Hommes D.W.

Created: Wednesday, 20 February 2019, 10:36 AM